AlphaNet, Inc.

ALPHANET

Education services, namely, providing classes, seminars, and workshops in the field Alpha-1 Antitrypsin Deficiency; providing on-line publications in the nature of guides and newsletters in the field of Alpha-1 Antitrypsin Deficiency; training of study staff in the field of Alpha-1 Antitrypsin Deficiency and clinical trials;Downloadable electronic publications in the nature of informational and educational materials, namely booklets, in the field of Alpha-1 Antitrypsin Deficiency; downloadable multimedia files containing artwork, text, audio and video relating to Alpha-1 Antitrypsin Deficiency; pre-recorded electronic media in the field of Alpha-1 Antitrypsin Deficiency;In the statement, Page 2, Column 1, lines 11-12, should be deleted, and Providing support and assistant in the nature of counseling to individuals affected by Alpha-1 Antitrypsin Deficiency; identifying qualified study sites, namely, inspection of laboratory research facilities for safety purposes should be inserted. In the statement, Page 2, Column 2, line 1, should be deleted.;Printed informational and educational materials, namely, booklets and reference guides, in the field of Alpha-1 Antitrypsin Deficiency;ALPHA NET;Charitable services, namely, providing financial support for clinical research to improve the lives of individuals affected by Alpha-1 Antitrypsin Deficiency;Providing support and assistance in the nature of counseling to individuals affected by Alpha-1 Antitrypsin Deficiency; Identifying qualified study sites, namely, inspection of laboratory research facilities for safety purposes;Health care services, namely, disease management for individuals affected by Alpha-1 Antitrypsin Deficiency; providing support and assistance services to inform individuals affected by Alpha-1 Antitrypsin Deficiency about the range of possible diagnoses and therapies to improve the quality of their lives; providing links to the web sites of others featuring information about the diagnosis, management and treatment of Alpha-1 Antitrypsin Deficiency; providing health and medical care information to individuals affected by Alpha-1 Antitrypsin Deficiency about the range of possible diagnoses and therapies to improve the quality of their lives, Providing support and assistance in the nature of health and wellness counseling to individuals affected by Alpha-1 Antitrypsin Deficiency;Providing medical and scientific research information in the field of Alpha-1 Antitrypsin Deficiency; consultation services in the field of facilitating and conducting clinical trials involving human subjects of new treatment options for individuals affected by Alpha-1 Antitrypsin Deficiency in the nature of identifying qualified study sites and researchers and encouraging study enrollment; providing quality assurance services in the field of clinical trials by generating and monitoring study data and documentation thereof for quality assurance purposes;

ALPHANETTER

Downloadable electronic publications in the nature of informational and educational materials, namely, newsletters, in the field of Alpha-1 Antitrypsin Deficiency;Printed informational and educational materials, namely, newsletters, in the field of Alpha-1 Antitrypsin Deficiency;ALPHA NETTER;

ALPHAS SERVING ALPHAS

Education services, namely, providing classes, seminars, and workshops in the field Alpha-1 Antitrypsin Deficiency; providing on-line publications in the nature of guides and newsletters in the field of Alpha-1 Antitrypsin Deficiency; training of study staff in the field of Alpha-1 Antitrypsin Deficiency and clinical trials;Downloadable electronic publications in the nature of informational and educational materials, namely, booklets, in the field of Alpha-1 Antitrypsin Deficiency; downloadable multimedia files containing artwork, text, audio and video relating to Alpha-1 Antitrypsin Deficiency; pre-recorded electronic media in the field of Alpha-1 Antitrypsin Deficiency;In the statement, Page 2, Column 2, lines 11-14, should be deleted, and Providing support and assistance in the nature of counseling to individuals affected by Alpha-1 Antitrypsin Deficiency; identifying qualified study sites, namely, inspection of laboratory research facilities for safety purposes should be inserted.;Printed informational and educational materials, namely, booklets and reference guides, in the field of Alpha-1 Antitrypsin Deficiency;Charitable services, namely, providing financial support for clinical research to improve the lives of individuals affected by Alpha-1 Antitrypsin Deficiency;Providing support and assistance in the nature of counseling to individuals affected by Alpha-1 Antitrypsin Deficiency; identifying qualified study sites, namely, inspection of laboratory research facilities for safety purposes;Health care services, namely, disease management for individuals affected by Alpha-1 Antitrypsin Deficiency; providing support and assistance services to inform individuals affected by Alpha-1 Antitrypsin Deficiency about the range of possible diagnoses and therapies to improve the quality of their lives; providing links to the web sites of others featuring information about the diagnosis, management and treatment of Alpha-1 Antitrypsin Deficiency; providing health and medical care information to individuals affected by Alpha-1 Antitrypsin Deficiency about the range of possible diagnoses and therapies to improve the quality of their lives, Providing support and assistance in the nature of health and wellness counseling to individuals affected by Alpha-1 Antitrypsin Deficiency;Providing medical and scientific research information in the field of Alpha-1 Antitrypsin Deficiency; consultation services in the field of facilitating and conducting clinical trials involving human subjects of new treatment options for individuals affected by Alpha-1 Antitrypsin Deficiency in the nature of identifying qualified study sites and researchers and encouraging study enrollment; providing quality assurance services in the field of clinical trials by generating and monitoring study data and documentation thereof for quality assurance purposes;

ALPHAVILLE

Electronic publications, namely, educational guides targeted to individuals affected by alpha-1 antitrypsin deficiency, recorded on computer media;Printed educational guides targeted to individuals affected by alpha-1 antitrypsin deficiency;ALPHAVILLE;

AN

Education services, namely, providing classes, seminars, and workshops in the field Alpha-1 Antitrypsin Deficiency; providing on-line publications in the nature of guides and newsletters in the field of Alpha-1 Antitrypsin Deficiency; training of study staff in the field of Alpha-1 Antitrypsin Deficiency and clinical trials;The mark consists of the letters AN in a stylized format.;Downloadable electronic publications in the nature of informational and educational materials, namely booklets, in the field of Alpha-1 Antitrypsin Deficiency; downloadable multimedia files containing artwork, text, audio and video relating to Alpha-1 Antitrypsin Deficiency; pre-recorded electronic media in the field of Alpha-1 Antitrypsin Deficiency;In the statement, Page 2, Column 2, lines 4-6, should be deleted, and Providing support and assistance in the nature of counseling to individuals affected by Alpha-1 Antitrypsin Deficiency; identifying qualified study sites, namely, inspection of laboratory research facilities for safety purposes should be inserted.;Printed informational and educational materials, namely, booklets and reference guides, in the field of Alpha-1 Antitrypsin Deficiency;ALPHA NET;Charitable services, namely, providing financial support for clinical research to improve the lives of individuals affected by Alpha-1 Antitrypsin Deficiency;Color is not claimed as a feature of the mark.;*Providing support and assistance in the nature of counseling to individuals affected by Alpha-1 Antitrypsin Deficiency;* Identifying qualified study sites, namely, inspection of laboratory research facilities for safety purposes;Health care services, namely, disease management for individuals affected by Alpha-1 Antitrypsin Deficiency; providing support and assistance services to inform individuals affected by Alpha-1 Antitrypsin Deficiency about the range of possible diagnoses and therapies to improve the quality of their lives; providing links to the web sites of others featuring information about the diagnosis, management and treatment of Alpha-1 Antitrypsin Deficiency; providing health and medical care information to individuals affected by Alpha-1 Antitrypsin Deficiency about the range of possible diagnoses and therapies to improve the quality of their lives; Providing support and assistance in the nature of health and wellness counseling to individuals affected by Alpha-1 Antitrypsin Deficiency;Providing medical and scientific research information in the field of Alpha-1 Antitrypsin Deficiency; consultation services in the field of facilitating and conducting clinical trials involving human subjects of new treatment options for individuals affected by Alpha-1 Antitrypsin Deficiency in the nature of identifying qualified study sites and researchers and encouraging study enrollment; providing quality assurance services in the field of clinical trials by generating and monitoring study data and documentation thereof for quality assurance purposes;

AN ALPHANET

AN ALPHA NET;HEALTH MANAGEMENT SERVICES, NAMELY, NURSING, PHARMACEUTICAL DISPENSING, PHYSICAL THERAPY, AND OXYGEN THERAPY SERVICES FOR THOSE AFFLICTED WITH ALPHA1 - ANTITRYPSIN DEFICIENCY AND THEIR PRIMARY CARE PROVIDERS;

BIG FAT REFERENCE GUIDE

Electronic publications, namely, educational guides targeted to individuals affected by alpha-1 antitrypsin deficiency, recorded on computer media;Printed educational guides targeted to individuals affected by alpha-1 antitrypsin deficiency;BIG FAT REFERENCE GUIDE;reference guide;

BIG FAT REFERENCE GUIDE

Providing on-line educational guides targeted to individuals affected by Alpha-1 Antitrypsin Deficiency;REFERENCE GUIDE;

COPD BIG FAT REFERENCE GUIDE (BFRG)

Providing on-line educational guides targeted to individuals affected by chronic obstructive pulmonary disease;Electronic publications, namely, educational guides targeted to individuals affected by chronic obstructive pulmonary disease, recorded on computer media;Printed educational guides targeted to individuals affected by chronic obstructive pulmonary disease;CHRONIC OBSTRUCTIVE PULMONARY DISEASE BIG FAT REFERENCE GUIDE (BFRG);COPD AND REFERENCE GUIDE;

SKINNY LITTLE REFERENCE GUIDE

Downloadable electronic publications in the nature of educational guides targeted to individuals affected by alpha-1 antitrypsin deficiency;Printed educational guides targeted to individuals affected by alpha-1 antitrypsin deficiency;REFERENCE GUIDE;

SLIM SKINNY REFERENCE GUIDE

Downloadable electronic publications in the nature of educational guides targeted to individuals affected by chronic obstructive pulmonary disease;Printed educational guides targeted to individuals affected by chronic obstructive pulmonary disease;REFERENCE GUIDE;